Literature DB >> 26621569

Medial Prefrontal Aberrations in Major Depressive Disorder Revealed by Cytoarchitectonically Informed Voxel-Based Morphometry.

Sebastian Bludau1, Danilo Bzdok1, Oliver Gruber1, Nils Kohn1, Valentin Riedl1, Christian Sorg1, Nicola Palomero-Gallagher1, Veronika I Müller1, Felix Hoffstaedter1, Katrin Amunts1, Simon B Eickhoff1.   

Abstract

OBJECTIVE: The heterogeneous human frontal pole has been identified as a node in the dysfunctional network of major depressive disorder. The contribution of the medial (socio-affective) versus lateral (cognitive) frontal pole to major depression pathogenesis is currently unclear. The authors performed morphometric comparison of the microstructurally informed subdivisions of human frontal pole between depressed patients and comparison subjects using both uni- and multivariate statistics.
METHOD: Multisite voxel- and region-based morphometric MRI analysis was conducted in 73 depressed patients and 73 matched comparison subjects without psychiatric history. Frontal pole volume was first compared between depressed patients and comparison subjects by subdivision-wise classical morphometric analysis. In a second approach, frontal pole volume was compared by subdivision-naive multivariate searchlight analysis based on support vector machines.
RESULTS: Subdivision-wise morphometric analysis found a significantly smaller medial frontal pole in depressed patients, with a negative correlation of disease severity and duration. Histologically uninformed multivariate voxel-wise statistics provided converging evidence for structural aberrations specific to the microstructurally defined medial area of the frontal pole in depressed patients.
CONCLUSIONS: Across disparate methods, subregion specificity in the left medial frontal pole volume in depressed patients was demonstrated. Indeed, the frontal pole was shown to structurally and functionally connect to other key regions in major depression pathology, such as the anterior cingulate cortex and the amygdala via the uncinate fasciculus. Present and previous findings consolidate the left medial portion of the frontal pole as particularly altered in major depression.

Entities:  

Mesh:

Year:  2015        PMID: 26621569      PMCID: PMC5441234          DOI: 10.1176/appi.ajp.2015.15030349

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  37 in total

1.  Distinct functional connectivity associated with lateral versus medial rostral prefrontal cortex: a meta-analysis.

Authors:  Sam J Gilbert; Gil Gonen-Yaacovi; Roland G Benoit; Emmanuelle Volle; Paul W Burgess
Journal:  Neuroimage       Date:  2010-07-21       Impact factor: 6.556

Review 2.  A review of feature selection techniques in bioinformatics.

Authors:  Yvan Saeys; Iñaki Inza; Pedro Larrañaga
Journal:  Bioinformatics       Date:  2007-08-24       Impact factor: 6.937

3.  Monkey to human comparative anatomy of the frontal lobe association tracts.

Authors:  Michel Thiebaut de Schotten; Flavio Dell'Acqua; Romain Valabregue; Marco Catani
Journal:  Cortex       Date:  2011-10-12       Impact factor: 4.027

4.  Reduced hippocampal volume correlates with executive dysfunctioning in major depression.

Authors:  Thomas Frodl; Annette Schaub; Sandra Banac; Marketa Charypar; Markus Jäger; Petra Kümmler; Ronald Bottlender; Thomas Zetzsche; Christine Born; Gerda Leinsinger; Maximilian Reiser; Hans-Jürgen Möller; Eva M Meisenzahl
Journal:  J Psychiatry Neurosci       Date:  2006-09       Impact factor: 6.186

5.  Limbic-frontal circuitry in major depression: a path modeling metanalysis.

Authors:  D A Seminowicz; H S Mayberg; A R McIntosh; K Goldapple; S Kennedy; Z Segal; S Rafi-Tari
Journal:  Neuroimage       Date:  2004-05       Impact factor: 6.556

Review 6.  Depression: what we can learn from postmortem studies.

Authors:  Grazyna Rajkowska
Journal:  Neuroscientist       Date:  2003-08       Impact factor: 7.519

Review 7.  Frontal-subcortical circuits and human behavior.

Authors:  J L Cummings
Journal:  Arch Neurol       Date:  1993-08

8.  Decreased muscarinic receptor binding in the frontal cortex of bipolar disorder and major depressive disorder subjects.

Authors:  A S Gibbons; E Scarr; C McLean; S Sundram; B Dean
Journal:  J Affect Disord       Date:  2008-12-21       Impact factor: 4.839

9.  Elevated 5-HT 2A receptors in postmortem prefrontal cortex in major depression is associated with reduced activity of protein kinase A.

Authors:  R C Shelton; E Sanders-Bush; D H Manier; D A Lewis
Journal:  Neuroscience       Date:  2008-12-03       Impact factor: 3.708

10.  Structural integrity of the uncinate fasciculus in geriatric depression: Relationship with age of onset.

Authors:  Warren D Taylor; James R MacFall; Guido Gerig; Ranga R Krishnan
Journal:  Neuropsychiatr Dis Treat       Date:  2007       Impact factor: 2.570

View more
  19 in total

Review 1.  Moving pharmacoepigenetics tools for depression toward clinical use.

Authors:  Laura M Hack; Gabriel R Fries; Harris A Eyre; Chad A Bousman; Ajeet B Singh; Joao Quevedo; Vineeth P John; Bernhard T Baune; Boadie W Dunlop
Journal:  J Affect Disord       Date:  2019-02-06       Impact factor: 4.839

2.  Behavior, sensitivity, and power of activation likelihood estimation characterized by massive empirical simulation.

Authors:  Danilo Bzdok; Claudia R Eickhoff; Simon B Eickhoff; Thomas E Nichols; Angela R Laird; Felix Hoffstaedter; Katrin Amunts; Peter T Fox
Journal:  Neuroimage       Date:  2016-05-11       Impact factor: 6.556

3.  Large-scale Meta-analysis Suggests Low Regional Modularity in Lateral Frontal Cortex.

Authors:  Alejandro de la Vega; Tal Yarkoni; Tor D Wager; Marie T Banich
Journal:  Cereb Cortex       Date:  2018-10-01       Impact factor: 5.357

4.  Cortical Connections Position Primate Area 25 as a Keystone for Interoception, Emotion, and Memory.

Authors:  Mary Kate P Joyce; Helen Barbas
Journal:  J Neurosci       Date:  2018-01-22       Impact factor: 6.167

5.  Functional Connectivity of the Subcallosal Cingulate Cortex And Differential Outcomes to Treatment With Cognitive-Behavioral Therapy or Antidepressant Medication for Major Depressive Disorder.

Authors:  Boadie W Dunlop; Justin K Rajendra; W Edward Craighead; Mary E Kelley; Callie L McGrath; Ki Sueng Choi; Becky Kinkead; Charles B Nemeroff; Helen S Mayberg
Journal:  Am J Psychiatry       Date:  2017-03-24       Impact factor: 18.112

Review 6.  The Impact of Stress and Major Depressive Disorder on Hippocampal and Medial Prefrontal Cortex Morphology.

Authors:  Emily L Belleau; Michael T Treadway; Diego A Pizzagalli
Journal:  Biol Psychiatry       Date:  2018-10-10       Impact factor: 13.382

7.  Local gyrification index in patients with major depressive disorder and its association with tryptophan hydroxylase-2 (TPH2) polymorphism.

Authors:  Kyu-Man Han; Eunsoo Won; June Kang; Aram Kim; Ho-Kyoung Yoon; Hun Soo Chang; Kyu Ri Son; Min-Soo Lee; Woo-Suk Tae; Byung-Joo Ham
Journal:  Hum Brain Mapp       Date:  2016-11-03       Impact factor: 5.038

8.  A single injection of pregabalin induces short- and long-term beneficial effects on fear memory and anxiety-like behavior in rats with experimental type-1 diabetes mellitus.

Authors:  Alvaro Henrique Bernardo de Lima Silva; Debora Rasec Radulski; Gabriela Saidel Pereira; Alexandra Acco; Janaina Menezes Zanoveli
Journal:  Metab Brain Dis       Date:  2022-03-03       Impact factor: 3.584

9.  Associations between subclinical depressive symptoms and reduced brain volume in middle-aged to older adults.

Authors:  Sarah M Szymkowicz; Adam J Woods; Vonetta M Dotson; Eric C Porges; Nicole R Nissim; Andrew O'Shea; Ronald A Cohen; Natalie C Ebner
Journal:  Aging Ment Health       Date:  2018-01-30       Impact factor: 3.658

10.  Hippocampal subregion volume in high-risk offspring is associated with increases in depressive symptoms across the transition to adolescence.

Authors:  Samantha Hubachek; Morgan Botdorf; Tracy Riggins; Hoi-Chung Leong; Daniel N Klein; Lea R Dougherty
Journal:  J Affect Disord       Date:  2020-12-09       Impact factor: 4.839

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.